T1	Participants 123 152	metastatic renal cell cancer.
T2	Participants 240 268	metastatic renal cell cancer
T3	Participants 277 285	Patients
T4	Participants 783 874	One hundred and eighty-three patients were enrolled between January 1998 and November 2003.
